Cybin Inc. (CYBN) Fundamentals

Cybin is focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders, all protected under its ever-growing IP portfolio.
SHARE INFORMATION
Market Cap$ 89,989,625
Shares Outstanding148,530,763
Float164,244,615
Percent Float100.0%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 1,356,721
Latest Fiscal EPS$ 0.00
Latest Fiscal Date2021-03-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions77
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months801,249
Institutional Holdings Percent13.2%
Institutional Sold Previous 3 Months7,978,480
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week High$ 3.38
52 Week Low$ 0.42
52 Week High Change$ -67.39
21 Day Moving Average$ 0.7029
21 Day Extended Moving Average$ 0.678565
50 Day Moving Average$ 0.7799
50 Day Extended Moving Average$ 0.79039
200 Day Moving Average$ 1.539
200 Day Extended Moving Average$ 1.2191
10 Day Average Volume804,258
20 Day Average Volume757,049
30 Day Average Volume809,542
50 Day Average Volume698,191
Alpha0.207235
Beta13.2170
Standard Deviation1.734769
R20.207292
7 Day Price Change$ -0.0655
7 Day Percent Change-10.68%
21 Day Price Change$ -0.2587
21 Day Percent Change-32.07%
30 Day Price Change$ -0.3321
30 Day Percent Change-37.74%
Month to Date Price Change$ -0.0281
Month to Date Percent Change-4.88%
Quarter to Date Price Change$ -0.2691
Quarter to Date Percent Change-32.94%
180 Day Price Change$ -1.56
180 Day Percent Change-74.03%
200 Day Price Change$ -1.42
200 Day Percent Change-72.19%
Year to Date Price Change$ -0.6521
Year to Date Percent Change-54.34%

Cybin Inc. (CYBN) Key Ratios

PROFITABILITY
EBIT Margin999,999.99%
EBITDA Margin9,957,892.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin23.1%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.90
Total Debt To Equity0.00
Int Coverage-1,300.10
Current Ratio11.40
Leverage Ratio1.10
Quick Ratio10.80
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-1.90
Enterprise Value$ 55,486,504
Price to Sales0.00
Price to Free Cash-3.40
PE High Last 5 Years0.00
Price To Book1.40
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book1.90
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-83.35
Return on Equity-91.70
Return on Capital-89.48

Cybin Inc. (CYBN) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorZeifmans LLP
CEODouglas Drysdale
Emplyoees-
Last AuditUQ
CIK0001833141
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address100 King Street West
Suite 5600
Toronto, ON M5X 1C9
Websitehttps://www.cybin.com
Facsimile-
Telephone+1 908 764-8385
Email-


Your Recent History
AMEX
CYBN
Cybin
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.